CVS Health Q4 revenue up 4.2% to $97.7B, adjusted EPS falls 44% to $1.19; FY25 guidance below consensus

CVS HEALTH Corp

2024-FY EPS reported $3.66 revenue$372,809,000,000

GAAP diluted EPS $1.30 (down $0.28 YoY); adjusted EPS $1.19 (down $0.93 YoY) on Health Care Benefits weakness.
Full-year 2024 total revenues $372.8B (+4.2% YoY); GAAP diluted EPS $3.66, adjusted EPS $5.42.
Health Care Benefits segment hurt by continued utilization pressure and unfavorable Medicare Advantage star ratings.
2025 guidance: GAAP diluted EPS $4.58-$4.83; adjusted EPS $5.75-$6.00; cash flow from ops ~$6.5B.
Pharmacy & Consumer Wellness segment showed growth, but overall earnings pressured by insurance challenges.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.